Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Applying Lessons Learned from COVID-19 Research and Development to Future Epidemics: Proceedings of a Workshop

Washington (DC): National Academies Press (US); 2023 Aug 23.
Free Books & Documents
Review

Applying Lessons Learned from COVID-19 Research and Development to Future Epidemics: Proceedings of a Workshop

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Global Health; Forum on Microbial Threats.
Free Books & Documents

Excerpt

The COVID-19 pandemic catalyzed unparalleled speed and cross-sector collaboration in the innovation of tools and technologies to address an emerging infectious disease outbreak. Continued innovation and collaboration in rapid development and implementation of new vaccines, therapeutics, and diagnostics is central to future outbreak preparedness. The National Academies Forum on Microbial Threats; Forum on Drug Discovery, Development, and Translation; and the Forum on Medical and Public Health Preparedness for Emergencies and Disasters held a workshop in December 2022 to explore how innovative approaches in research can enhance health systems preparedness and responses to emerging infectious diseases and dangerous pathogens. Workshop participants reflected on critical scientific infrastructure for stakeholder coordination and innovations that can facilitate rapid and effective preparedness and response to emerging infectious disease threats. This Proceedings of a Workshop summarizes the discussions held during the workshop.

PubMed Disclaimer

Grants and funding

This activity was supported by contracts between the National Academy of Sciences and American Society of Tropical Medicine and Hygiene, Burroughs Wellcome Fund, Centers of Disease Control and Prevention (Contract No. 75D30121D11240), EcoHealth Alliance, ExxonMobil Foundation, Infectious Diseases Society of America, Johnson & Johnson (Contract No. C2022024120), Merck & Co., Inc., National Institute of Allergy and Infectious Diseases (Contract No. HHSN263201800029I, Task No. HHSN26300011), New Venture Fund (Contract No. NVF-NGDF-NAT10-Subgrant-017387-2022-04-01), Rockefeller Foundation, Sanofi, Society of Infectious Diseases Pharmacists, U.S. Agency for International Development (Grant No. 7200AA18GR00003), Uniformed Services University of Health Sciences (Award No. HU00012210001), U.S. Food and Drug Administration (Award No. 5R13FD006897-03), U.S. Department of Veterans Affairs (Contract No. 36C25022Q1147). Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.

LinkOut - more resources